Ying Shi
- Hepatology top 5%
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases 9
- IL-33, ST2, and ILC Pathways 3
- Immune Cell Function and Interaction 3
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 7
- Adipokines, Inflammation, and Metabolic Diseases 5
- Rehabilitation top 10%
-
- Kidney Stones and Urolithiasis Treatments 3
- Aortic aneurysm repair treatments 3
- Aortic Disease and Treatment Approaches 3
- Co-authors
- Yingzhong LinQingwei JiLei ShiLing LiuYing HuangZhengde LuQiutang ZengTao Zeng
- Cited by
- HepatologyImmunologyEpidemiology
- Partner nations
- ChinaJapanSwitzerland
In The Last Decade
Ying Shi
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Hepatology 165
- Immunology 375
- Epidemiology 364
- Cardiology and Cardiovascular Medicine 199
- Rehabilitation 47
Countries citing papers authored by Ying Shi
This map shows the geographic impact of Ying Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Shi more than expected).
Fields of papers citing papers by Ying Shi
This network shows the impact of papers produced by Ying Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Shi. The network helps show where Ying Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 26 | |
| 8 | 2022 | 26 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 43 | |
| 12 | 2020 | 22 | |
| 13 | 2020 | 11 | |
| 14 | 2020 | 27 | |
| 15 | 2020 | 3 | |
| 16 | 2019 | 39 | |
| 17 | 2018 | 37 | |
| 18 | 2018 | 47 | |
| 19 | 2013 | 0 | |
| 20 | 2012 | 64 |
About Ying Shi
Ying Shi is a scholar working on Biological Psychiatry, Immunology and Hepatology, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (9 papers), Liver Disease Diagnosis and Treatment (7 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers), Kidney Stones and Urolithiasis Treatments (3 papers), Aortic aneurysm repair treatments (3 papers), Aortic Disease and Treatment Approaches (3 papers), IL-33, ST2, and ILC Pathways (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Hepatology (165 citations), Immunology (375 citations) and Epidemiology (364 citations). Ying Shi has collaborated with scholars based in China, Japan and Switzerland. Frequent co-authors include Yingzhong Lin, Qingwei Ji, Lei Shi, Ling Liu, Ying Huang, Zhengde Lu, Qiutang Zeng, Tao Zeng, Zhen Wang and Bangwei Wu. Their work appears in journals such as Clinica Chimica Acta, Medicine, Life Sciences, Journal of Cellular and Molecular Medicine and Infection and Drug Resistance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.